---
schema_version: "secwatch.filing_event.v1"
accession: "0001099800-23-000032"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2023-07-26T23:59:59+00:00"
generated_at: "2026-06-13T02:13:02.748481+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Edwards Q2 sales $1.53B (+11% YoY); adj EPS $0.66; raises FY23 guidance

## Summary
- Q2 sales $1.53B (+11%/+12% constant currency); GAAP EPS $0.50 (incl. IP charge), adjusted EPS $0.66.
- TAVR sales $992M (+9%/+10% constant currency); TMTT $48M; Surgical $256M; Critical Care $235M.
- Raised FY2023 sales guide to $5.9-$6.1B (prior $5.6-$6.0B), constant currency growth 10-13%.
- Adjusted EPS guide raised to $2.50-$2.60 (prior $2.48-$2.60); Q3 guide $1.44-$1.52B sales, $0.55-$0.61 adj EPS.
- Adjusted gross margin 77.7% (vs 80.5% YoY); $300M IP payment; cash $1.5B, debt $600M.

## SEC filing metadata
- accession: 0001099800-23-000032
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2023-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000109980023000032/0001099800-23-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000109980023000032/ew-20230726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001099800-23-000032
- JSON: https://secwatch.observer/filing/0001099800-23-000032.json
- Plain text: https://secwatch.observer/filing/0001099800-23-000032.txt

## Key facts
- Earnings Releases
  Edwards Lifesciences Corp updated its second quarter of 2023 guidance (raised).
  - Period: second quarter of 2023
  - Guidance: raised
  - Result: reported results
  source text: On July 26, 2023, Edwards Lifesciences Corporation, a Delaware corporation (“Edwards”), issued a press release setting forth Edwards’ financial results for the second quarter of 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1099800/000109980023000032/0001099800-23-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.